Targeting angiogenesis for the treatment of prostate cancer

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations


Introduction : While multiple therapies exist that prolong the lives of men with advanced prostate cancer, none are curative. This had led to a search to uncover novel targets for prostate cancer therapy, distinct from those of traditional hormonal approaches, chemotherapies, immunotherapies and bone-targeting approaches. The process of tumor angiogenesis is one target that is being exploited for therapeutic gain. Areas covered : The most promising anti-angiogenic approaches for treatment of prostate cancer, focusing on clinical development of selected agents. These include VEGF-directed therapies, tyrosine kinase inhibitors, tumor-vascular disrupting agents, immunomodulatory drugs and miscellaneous anti-angiogenic agents. While none of these drugs have yet entered the market for the treatment of prostate cancer, several are now being tested in Phase III registrational trials. Expert opinion : The development of anti-angiogenic agents for prostate cancer has met with several challenges. This includes discordance between traditional prostate-specific antigen responses and clinical responses, which have clouded clinical trial design and interpretation, potential inadequate exposure to anti-angiogenic therapies with premature discontinuation of study drugs and the development of resistance to anti-angiogenic monotherapies. These barriers will hopefully be overcome with the advent of more potent agents, the use of dual angiogenesis inhibition and the design of more informative clinical trials.

Original languageEnglish (US)
Pages (from-to)365-376
Number of pages12
JournalExpert opinion on therapeutic targets
Issue number4
StatePublished - Apr 2012


  • angiogenesis
  • bevacizumab
  • cabozantinib
  • clinical trials
  • drug development
  • itraconazole
  • lenalidomide
  • prostate cancer
  • sunitinib
  • tasquinimod
  • vadimezan

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry


Dive into the research topics of 'Targeting angiogenesis for the treatment of prostate cancer'. Together they form a unique fingerprint.

Cite this